Mar. 16, 2026 A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans swears by her local family-run drugstore for holiday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results